172 related articles for article (PubMed ID: 31483045)
1. [The incorporation of nusinersen by the Brazilian Unified National Health System: critical thoughts on the institutionalization of health technology assessment in Brazil].
Caetano R; Hauegen RC; Osorio-de-Castro CGS
Cad Saude Publica; 2019 Aug; 35(8):e00099619. PubMed ID: 31483045
[TBL] [Abstract][Full Text] [Related]
2. Incorporation of new medicines by the National Commission for Incorporation of Technologies, 2012 to June 2016.
Caetano R; Silva RMD; Pedro ÉM; Oliveira IAG; Biz AN; Santana P
Cien Saude Colet; 2017 Aug; 22(8):2513-2525. PubMed ID: 28793068
[TBL] [Abstract][Full Text] [Related]
3. Incorporation of drugs for rare diseases in Brazil: is it possible to have full access to these patients?
Biglia LV; Mendes SJ; Lima TM; Aguiar PM
Cien Saude Colet; 2021 Nov; 26(11):5547-5560. PubMed ID: 34852089
[TBL] [Abstract][Full Text] [Related]
4. [Use of health technology assessment in decision-making processes by the Brazilian Ministry of Health on the incorporation of technologies in the Brazilian Unified National Health System].
Novaes HM; Elias FT
Cad Saude Publica; 2013 Nov; 29 Suppl 1():S7-16. PubMed ID: 25402252
[TBL] [Abstract][Full Text] [Related]
5. Health technology reassessment in the Brazilian public health system: Analysis of the current status.
Pereira VC; Barreto JOM; Neves FADR
PLoS One; 2019; 14(7):e0220131. PubMed ID: 31356609
[TBL] [Abstract][Full Text] [Related]
6. Incorporation of medicines in the Unified Health System (SUS): comparison between oncology and the specialized component of pharmaceutical care.
Capucho HC; Brito A; Maiolino A; Kaliks RA; Pinto RP
Cien Saude Colet; 2022 Jun; 27(6):2471-2479. PubMed ID: 35649033
[TBL] [Abstract][Full Text] [Related]
7. Challenges to decision-making processes in the national HTA agency in Brazil: operational procedures, evidence use and recommendations.
Yuba TY; Novaes HMD; de Soárez PC
Health Res Policy Syst; 2018 May; 16(1):40. PubMed ID: 29751764
[TBL] [Abstract][Full Text] [Related]
8. [Multi-criteria decision analysis for health technology resource allocation and assessment: so far and so near?].
Campolina AG; Soárez PC; Amaral FVD; Abe JM
Cad Saude Publica; 2017 Oct; 33(10):e00045517. PubMed ID: 29091169
[TBL] [Abstract][Full Text] [Related]
9. Health technology assessment in Brazil - an international perspective.
Lima SGG; Brito C; Andrade CJC
Cien Saude Colet; 2019 May; 24(5):1709-1722. PubMed ID: 31166506
[TBL] [Abstract][Full Text] [Related]
10. Social participation in the health technology incorporation process into Unified Health System.
Silva AS; Sousa MSA; Silva EVD; Galato D
Rev Saude Publica; 2019; 53():109. PubMed ID: 31859904
[TBL] [Abstract][Full Text] [Related]
11. How health economic evaluation (HEE) contributes to decision-making in public health care: the case of Brazil.
Elias FT; Araújo DV
Z Evid Fortbild Qual Gesundhwes; 2014; 108(7):405-12. PubMed ID: 25444299
[TBL] [Abstract][Full Text] [Related]
12. [Does the pharmaceutical industry interfere in the sustainability of the public health system in Brazil? A reflection on the pressure for the incorporation of medicines].
Tamachiro ST; Gonçalves FAR; Simone ALM; Aguiar PM
Cad Saude Publica; 2022; 38(7):e00233321. PubMed ID: 35894368
[TBL] [Abstract][Full Text] [Related]
13. Reversal of the recommendations issued by the National Commission for the Incorporation of Technologies in SUS after Public Consultations.
Lopes SGP; Luiza VL; Silva RMD
Cien Saude Colet; 2023 Feb; 28(2):561-573. PubMed ID: 36651407
[TBL] [Abstract][Full Text] [Related]
14. Expert consensus (SBC/SBHCI) on the use of drug-eluting stents: recommendations of the Brazilian society of interventional cardiology/ Brazilian society of cardiology for the Brazilian public single healthcare system.
Lima VC; Mattos LA; Caramori PR; Perin MA; Mangione JA; Machado BM; Coelho WM; Bueno RR
Arq Bras Cardiol; 2006 Oct; 87(4):e162-7. PubMed ID: 17128305
[TBL] [Abstract][Full Text] [Related]
15. Exploring the COVID-19 Pandemic's Impact on the Health Technology Assessment Process of the National Commission for the Incorporation of Technologies Into the Brazilian Health System.
Cardoso MMA; Thabane L; Andrade LGM; Curado DDSP; Komoda DS; Machado-Rugolo J; Lima SAM; Weber SAT
Value Health Reg Issues; 2023 Sep; 37():18-22. PubMed ID: 37196546
[TBL] [Abstract][Full Text] [Related]
16. Institutionalizing Health Technology Assessment in Brazil: Challenges Ahead.
Kuchenbecker R; Polanczyk CA
Value Health Reg Issues; 2012 Dec; 1(2):257-261. PubMed ID: 29702910
[TBL] [Abstract][Full Text] [Related]
17. Nusinersen: A Treatment for Spinal Muscular Atrophy.
Claborn MK; Stevens DL; Walker CK; Gildon BL
Ann Pharmacother; 2019 Jan; 53(1):61-69. PubMed ID: 30008228
[TBL] [Abstract][Full Text] [Related]
18. Nusinersen treatment of spinal muscular atrophy: current knowledge and existing gaps.
Gidaro T; Servais L
Dev Med Child Neurol; 2019 Jan; 61(1):19-24. PubMed ID: 30221755
[TBL] [Abstract][Full Text] [Related]
19. Technological incorporation in the Unified Health System (SUS): the problem and ensuing challenges.
Guimarães R
Cien Saude Colet; 2014 Dec; 19(12):4899-908. PubMed ID: 25388198
[TBL] [Abstract][Full Text] [Related]
20. [Health technology assessment: experience in the Ministry of Health of Brazil].
Silva MT
Rev Peru Med Exp Salud Publica; 2011; 28(3):548-51. PubMed ID: 22086639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
